{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T00:22:02Z","timestamp":1760746922297,"version":"build-2065373602"},"reference-count":45,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T00:00:00Z","timestamp":1760572800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"College of Health Science"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CIMB"],"abstract":"<jats:p>Prediabetes is an intermediate stage between normoglycaemia and type 2 diabetes mellitus (T2DM), affecting over 425 million people globally and contributing to vascular damage and increased stroke risk. Despite the severity of both conditions, their association remains underexplored. This review examines the literature on stroke-related biomarkers in normoglycaemia, prediabetes and T2DM to identify potential links between prediabetes and stroke. This systematic review followed PRISMA-2020 guidelines. PubMed, Google Scholar, Scopus, Web of Science and Science Direct were searched for studies (2003\u20132023) on stroke biomarkers in prediabetes. Eligible studies were original human research in English, with defined diagnostic criteria (ADA or WHO) for glycaemic status and reported biomarker associations or stroke risk. Studies with major comorbidities were excluded. Data were extracted and bias was assessed using the Newcastle\u2013Ottawa Scale. Meta-analysis was not performed due to limited studies per biomarker. Eight studies (n = 3003) were included. NSE was examined in three studies, all reporting significant elevations in hyperglycaemic individuals. Interleukin-6 (IL-6) was assessed in two studies; one showed a significant increase in diabetes, while the other found a non-significant upward trend. D-dimer and GFAP were each reported in separate single studies, both showing significant elevations in hyperglycaemic individuals with stroke or neurocognitive impairment. S100B was investigated in two studies, with divergent findings: one showed a positive association with glycaemic status, while the other reported lower levels in hyperglycaemia. Findings indicate biomarker alterations in T2DM, suggesting that early changes may occur in prediabetes. Our review suggests that individuals with prediabetes may show alterations in inflammatory (IL-6), coagulation (D-dimer), and neurovascular (S100B, GFAP, NSE) markers, though some findings are inconsistent, reflecting early pathophysiological changes that may increase stroke risk. Further well-designed studies are needed to clarify these associations and establish biomarker-based tools for earlier stroke risk detection and prevention in individuals with prediabetes.<\/jats:p>","DOI":"10.3390\/cimb47100854","type":"journal-article","created":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T11:39:34Z","timestamp":1760701174000},"page":"854","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pathophysiological Links Between Stroke and Prediabetes: A Systematic Review"],"prefix":"10.3390","volume":"47","author":[{"given":"Yerushka","family":"Naicker","sequence":"first","affiliation":[{"name":"Department of Human Physiology, School of Laboratory Medicine and Medical Sciences, College of Health Sciences, University of KwaZulu-Natal, Durban 3629, South Africa"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2246-0038","authenticated-orcid":false,"given":"Andile","family":"Khathi","sequence":"additional","affiliation":[{"name":"Department of Human Physiology, School of Laboratory Medicine and Medical Sciences, College of Health Sciences, University of KwaZulu-Natal, Durban 3629, South Africa"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,10,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.mpmed.2010.08.008","article-title":"What is type 2 diabetes?","volume":"38","author":"Smushkin","year":"2010","journal-title":"Medicine"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/nrendo.2017.151","article-title":"Global aetiology and epidemiology of type 2 diabetes mellitus and its complications","volume":"14","author":"Zheng","year":"2018","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"109119","DOI":"10.1016\/j.diabres.2021.109119","article-title":"IDF Diabetes Atlas: Global, regional and country-level diabetes prsevalence estimates for 2021 and projections for 2045","volume":"183","author":"Sun","year":"2022","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.lpm.2013.02.313","article-title":"Complications du diab\u00e8te de type 2","volume":"42","author":"Schlienger","year":"2013","journal-title":"La Presse M\u00e9dicale"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.mpmed.2020.06.002","article-title":"Stroke: Causes and clinical features","volume":"48","author":"Murphy","year":"2020","journal-title":"Medicine"},{"key":"ref_6","first-page":"3238165","article-title":"Stroke in the 21st Century: A Snapshot of the Burden, Epidemiology, and Quality of Life","volume":"2018","author":"Donkor","year":"2018","journal-title":"Stroke Res. Treat."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1159\/000094249","article-title":"Impact of Female Gender on Prognosis in Type 2 Diabetic Patients with Ischemic Stroke","volume":"56","author":"Arboix","year":"2006","journal-title":"Eur. Neurol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1186\/s12933-023-01979-1","article-title":"Inflammation and oxidative stress markers in type 2 diabetes patients with Advanced Carotid atherosclerosis","volume":"22","author":"Laubriet","year":"2023","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Galicia-Garcia, U., Benito-Vicente, A., Jebari, S., Larrea-Sebal, A., Siddiqi, H., Uribe, K.B., Ostolaza, H., and Mart\u00edn, C. (2020). Pathophysiology of Type 2 Diabetes Mellitus. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21176275"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S2213-8587(19)30405-X","article-title":"Cerebral microvascular complications of type 2 diabetes: Stroke, cognitive dysfunction, and depression","volume":"8","author":"Sedaghat","year":"2020","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Ding, P.F., Zhang, H.S., Wang, J., Gao, Y.Y., Mao, J.N., Hang, C.H., and Li, W. (2022). Insulin resistance in ischemic stroke: Mechanisms and therapeutic approaches. Front. Endocrinol., 13.","DOI":"10.3389\/fendo.2022.1092431"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1007\/s12017-019-08530-0","article-title":"Blood Biomarkers for Stroke Diagnosis and Management","volume":"21","author":"Jickling","year":"2019","journal-title":"Neuromol. Med."},{"key":"ref_13","unstructured":"Alvarez, S., Coffey, R., Mathias, P.M., and Algotar, A.M. (2024). Prediabetes. StatPearls, StatPearls Publishing LLC.. Copyright \u00a9 2024."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1146\/annurev-publhealth-090419-102644","article-title":"Prediabetes and What It Means: The Epidemiological Evidence","volume":"42","author":"Selvin","year":"2021","journal-title":"Annu. Rev. Public Health"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1177\/1535370216654227","article-title":"Prediabetes as a toxic environment for the initiation of microvascular and macrovascular complications","volume":"241","author":"Brannick","year":"2016","journal-title":"Exp. Biol. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.2337\/dc22-2376","article-title":"Global Prevalence of Prediabetes","volume":"46","author":"Rooney","year":"2023","journal-title":"Diabetes Care"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"26","DOI":"10.5853\/jos.2022.02306","article-title":"Diabetes and Stroke: What Are the Connections?","volume":"25","author":"Mosenzon","year":"2023","journal-title":"J. Stroke"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"n160","DOI":"10.1136\/bmj.n160","article-title":"PRISMA 2020 explanation and elaboration: Updated guidance and exemplars for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s40842-019-0080-0","article-title":"Global epidemiology of prediabetes\u2014Present and future perspectives","volume":"5","author":"Hostalek","year":"2019","journal-title":"Clin. Diabetes Endocrinol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e3564","DOI":"10.1136\/bmj.e3564","article-title":"Effect of pre-diabetes on future risk of stroke: Meta-analysis","volume":"344","author":"Lee","year":"2012","journal-title":"BMJ Br. Med. J."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/nrneurol.2010.129","article-title":"Imaging of acute stroke","volume":"6","author":"Merino","year":"2010","journal-title":"Nat. Rev. Neurol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/j.1600-0404.2005.00416.x","article-title":"IL-6: An early marker for outcome in acute ischemic stroke","volume":"111","author":"Ulvestad","year":"2005","journal-title":"Acta Neurol. Scand."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Yao, T., Tian, B.-L., Li, G., Cui, Q., Wang, C.-f., Zhang, Q., Peng, B., Gao, Y., Zhan, Y.-Q., and Hu, D. (2019). Elevated plasma D-dimer levels are associated with short-term poor outcome in patients with acute ischemic stroke: A prospective, observational study. BMC Neurol., 19.","DOI":"10.1186\/s12883-019-1386-3"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"di Biase, L., Bonura, A., Pecoraro, P.M., Carbone, S.P., and Di Lazzaro, V. (2023). Unlocking the Potential of Stroke Blood Biomarkers: Early Diagnosis, Ischemic vs. Haemorrhagic Differentiation and Haemorrhagic Transformation Risk: A Comprehensive Review. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241411545"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"260s","DOI":"10.1093\/ajh\/6.7.260S","article-title":"Hyperinsulinemia, insulin resistance, and hyperglycemia: Contributing factors in the pathogenesis of hypertension and atherosclerosis","volume":"6","author":"Sowers","year":"1993","journal-title":"Am. J. Hypertens"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1161\/STROKEAHA.119.024157","article-title":"Inflammation, Autoimmunity, Infection, and Stroke: Epidemiology and Lessons from Therapeutic Intervention","volume":"51","author":"Parikh","year":"2020","journal-title":"Stroke"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Huang, K., Liang, Y., Ma, Y., Wu, J., Luo, H., and Yi, B. (2022). The Variation and Correlation of Serum Adiponectin, Nesfatin-1, IL-6, and TNF-\u03b1 Levels in Prediabetes. Front. Endocrinol., 13.","DOI":"10.3389\/fendo.2022.774272"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Didion, S.P. (2017). Cellular and Oxidative Mechanisms Associated with Interleukin-6 Signaling in the Vasculature. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18122563"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00592-010-0198-0","article-title":"The predictive value of TNF-\u03b1 and IL-6 and the incidence of macrovascular complications in patients with type 2 diabetes","volume":"49","author":"Wu","year":"2012","journal-title":"Acta Diabetol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0024-3205(00)00622-6","article-title":"Plasma interleukin-6, tumour necrosis factor alpha and blood cytokine production in type 2 diabetes","volume":"67","author":"Pickup","year":"2000","journal-title":"Life Sci."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1615\/CritRevEukaryotGeneExpr.2017019712","article-title":"Role of Interleukin-6 in Development of Insulin Resistance and Type 2 Diabetes Mellitus","volume":"27","author":"Rehman","year":"2017","journal-title":"Crit. Rev. Eukaryot. Gene Expr."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1161\/STROKEAHA.120.033217","article-title":"D-dimer Level as a Predictor of Recurrent Stroke in Patients with Embolic Stroke of Undetermined Source","volume":"52","author":"Choi","year":"2021","journal-title":"Stroke"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Cheng, L., Fu, Q., Zhou, L., Fan, Y., Liu, F., Fan, Y., Zhang, X., Lin, W., and Wu, X. (2022). D-dimer as a predictor of cardiovascular outcomes in patients with diabetes mellitus. BMC Cardiovasc. Disord., 22.","DOI":"10.1186\/s12872-022-02531-x"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Prabhakar, H. (2017). Chapter 33\u2014Biomarkers in Traumatic Brain Injury. Essentials of Neuroanesthesia, Academic Press.","DOI":"10.1201\/9781315154367"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.tins.2015.04.003","article-title":"Glial fibrillary acidic protein: From intermediate filament assembly and gliosis to neurobiomarker","volume":"38","author":"Yang","year":"2015","journal-title":"Trends Neurosci."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.arcmed.2022.06.001","article-title":"Serum Levels of Glial Fibrillary Acidic Protein Association with Cognitive Impairment and Type 2 Diabetes","volume":"53","year":"2022","journal-title":"Arch. Med. Res."},{"key":"ref_37","first-page":"2109","article-title":"How S100B crosses brain barriers and why it is considered a peripheral marker of brain injury","volume":"248","author":"Vizuete","year":"2023","journal-title":"Exp. Biol. Med."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Huang, Y., Wang, Z., Huang, Z.X., and Liu, Z. (2023). Biomarkers and the outcomes of ischemic stroke. Front. Mol. Neurosci., 16.","DOI":"10.3389\/fnmol.2023.1171101"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"3405","DOI":"10.2337\/dc13-0590","article-title":"NSE, a potential biomarker, is closely connected to diabetic peripheral neuropathy","volume":"36","author":"Li","year":"2013","journal-title":"Diabetes Care"},{"key":"ref_40","first-page":"275","article-title":"Diagnostic value of initial s-100b and neuron- specific enolase levels in diabetic patients with ischemic stroke","volume":"27","author":"Roshdy","year":"2007","journal-title":"Bull. Egypt. Soc. Physiol. Sci."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"50","DOI":"10.4103\/0976-3147.80099","article-title":"Correlative study between neuron-specific enolase and blood sugar level in ischemic stroke patients","volume":"2","author":"Pandey","year":"2011","journal-title":"J. Neurosci. Rural. Pract."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1159\/000449480","article-title":"Prediction of Outcome in Diabetic Acute Ischemic Stroke Patients: A Hospital-Based Pilot Study Report","volume":"23","author":"Nayak","year":"2016","journal-title":"Ann. Neurosci."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"4193","DOI":"10.18632\/aging.102873","article-title":"Levels of serum S100B are associated with cognitive dysfunction in patients with type 2 diabetes","volume":"12","author":"Yu","year":"2020","journal-title":"Aging"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"7246373","DOI":"10.1155\/2023\/7246373","article-title":"Serum Markers of Neuronal Damage and Astrocyte Activity in Patients with Chronic Epilepsy: Elevated Levels of Glial Fibrillary Acidic Protein","volume":"2023","author":"Mochol","year":"2023","journal-title":"Acta Neurol. Scand."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s00701-011-1175-2","article-title":"The usefulness of S100B, NSE, GFAP, NF-H, secretagogin and Hsp70 as a predictive biomarker of outcome in children with traumatic brain injury","volume":"154","author":"Fedora","year":"2012","journal-title":"Acta Neurochir."}],"container-title":["Current Issues in Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1467-3045\/47\/10\/854\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T12:41:59Z","timestamp":1760704919000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1467-3045\/47\/10\/854"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,16]]},"references-count":45,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["cimb47100854"],"URL":"https:\/\/doi.org\/10.3390\/cimb47100854","relation":{},"ISSN":["1467-3045"],"issn-type":[{"value":"1467-3045","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,16]]}}}